Undervalued Growth and Dividend Growth in Health Technology: Part 11

Introduction Although many Health Technology Sector companies have significantly outperformed the market on a long-term basis, they have significantly underperformed the market since the beginning of 2015.  With only a few minor exceptions, this is true for most companies, especially the pharmaceutical companies, operating in this sector. On the other hand, there are several examples Read more about Undervalued Growth and Dividend Growth in Health Technology: Part 11[…]